ONCONIX: A revolutionary organoid culturing and drug efficacy testing platform for personalized response prediction to cancer therapies

Font Standard Bold
Login

Project search
Actual Project
Recent projects
Graphics
Login

Research unit

INNOSUISSE

Project number

101.951 IP-LS

Project title

ONCONIX: A revolutionary organoid culturing and drug efficacy testing platform for personalized response prediction to cancer therapies (Innolink: 101

Basic data
Texts
Participants

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Inserted texts

Category	Text
Key words (English)	Life sciences, Personalised medicine
Abstract (English)	We will deliver ONCONIX: a highly innovative personalized treatment-response prediction platform for oncology based on uniquely rapid patient-derived organoid cultures and in-house developed machine learning models. Here, we will perform a non-interventional proof-of-concept study in bladder cancer.